- Joined
- Nov 9, 2010
- Messages
- 80,748
- Points
- 113
The factory in Tuas Biomedical Park can produce three or four different types of vaccines simultaneously, as compared with current industrial sites which usually allow for the production of only one vaccine at any one time, Sanofi noted.
This is because the new facility will tap digital technologies and single-use systems (SUSs) in vaccine manufacturing, said Sanofi Pasteur senior vice-president Vincent Hingot, who is also head of global vaccines industrial affairs.
SUSs allow multiple vaccines to be made in a single suite at reduced costs, among other benefits.
This is because the new facility will tap digital technologies and single-use systems (SUSs) in vaccine manufacturing, said Sanofi Pasteur senior vice-president Vincent Hingot, who is also head of global vaccines industrial affairs.
SUSs allow multiple vaccines to be made in a single suite at reduced costs, among other benefits.